Best Antibiotic for Human Bites
Amoxicillin-clavulanate 875/125 mg twice daily is the first-line antibiotic for human bite wounds 1.
First-Line Treatment
The 2014 IDSA guidelines explicitly recommend amoxicillin-clavulanate as the primary oral antibiotic for human bites 1. This combination provides coverage against the polymicrobial flora characteristic of human bite wounds, including:
- Eikenella corrodens (a key pathogen unique to human bites)
- Staphylococcus aureus
- Streptococcus species
- Anaerobes from oral flora
For severe infections requiring IV therapy, ampicillin-sulbactam 1.5-3.0 g every 6 hours is the recommended alternative 1.
Alternative for Penicillin-Allergic Patients
Doxycycline 100 mg twice daily is the recommended alternative for penicillin-allergic patients 1. The guidelines specifically note that doxycycline has "good activity against Eikenella species, staphylococci, and anaerobes," though some streptococci may be resistant 1.
Important Caveat
The beta-lactam options (amoxicillin-clavulanate, ampicillin-sulbactam) miss MRSA coverage 1. If MRSA is suspected or the patient has risk factors (prior MRSA infection, healthcare exposure, injection drug use), add vancomycin or consider alternative coverage.
Tetanus Prophylaxis
Always assess tetanus vaccination status for bite wounds 2, 3, 4. Provide a tetanus booster if:
- Last dose was >5 years ago for contaminated wounds
- Last dose was >10 years ago for clean wounds
- Vaccination history is unknown or incomplete
Duration of Therapy
- Prophylaxis: 3-5 days for early presentation with uninfected wounds at high risk 2
- Treatment of established infection: 10-14 days 2
Critical Clinical Considerations
High-risk human bites requiring aggressive management:
- Clenched-fist injuries (fight bites over the metacarpophalangeal joints) - these have the worst prognosis due to deep inoculation into joint spaces, tendons, and bone 5, 6
- Hand bites of any type
- Bites with joint, bone, or tendon involvement
- Wounds presenting >24 hours after injury
- Immunocompromised or asplenic patients
Common pitfall: The older literature overstated infection rates for all human bites based on delayed-presentation clenched-fist injuries 6. Human bites to the face, lips, and ears actually have very low infection rates (<3%) when properly treated early 6. However, hand bites—especially clenched-fist injuries—remain extremely high-risk and warrant aggressive irrigation, debridement, and close follow-up.
Wound Management Algorithm
- Irrigate copiously with normal saline or warm water
- Debride devitalized tissue and remove foreign bodies
- Leave most wounds open for delayed closure, especially high-risk wounds 2, 5
- Primary closure may be considered only for low-risk facial wounds presenting early (<24 hours) without signs of infection 5
- Culture all infected wounds to guide antibiotic adjustment 7
Human bites differ fundamentally from animal bites in their microbiology—they lack Pasteurella multocida but commonly harbor Eikenella corrodens 8, 5, making the beta-lactamase inhibitor combinations essential for adequate coverage.